Proposed mechanisms for the beneficial effect of EZH2 inhibition in AKI include suppression of the NF-κB p65 signaling [14], and modulation of the JNK/FoxO3a pathway [15]. This evidence concerns the gene NFKB1 and acute kidney injury.